the SRIW Life Sciences
VC Fund
the SRIW Life Sciences is a VC fund focused on Biotechnology and Medical. the SRIW Life Sciences
- Total investments:
- 3
- Last investment:
- Lead investor:
- 33%
Last updated:
For AI agents: llms.txt
Industries the SRIW Life Sciences invests in
Stages the SRIW Life Sciences invests in
Countries the SRIW Life Sciences invests in
Round sizes
Round size
- Series B
- $22M–$23M
Investment Focus
Industry
- Biotechnology 2 (67%)
- Medical 1 (33%)
- Biopharma 1 (33%)
- Health Care 1 (33%)
- Life Science 1 (33%)
Stage
- Series A 1 (33%)
- Series B 1 (33%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Novadip Biosciences, an advanced biopharmaceutical company focused on new generation of therapies from adipose stem cells adapted to hard and soft tissues reconstruction. | $23.4M / Series B / Nov 03, 2022 | ||
| Novadip Biosciences, an advanced biopharmaceutical company focused on new generation of therapies from adipose stem cells adapted to hard and soft tissues reconstruction. | $22.2M / Series B / Oct 28, 2021 | ||
| A-Mansia Biotech is a developer of products based on the properties of the Akkermansia muciniphila (A. muciniphila) bacterium. The company's nutritional supplement based on a gut bacterium called Akkermansia, the population of microorganisms housed in the gastrointestinal tract. A. muciniphila is located in the mucus layer covering theintestinal epithelium, which allows the bacterium to establish a close cross-talk with the host. | $15.8M / Series A / Apr 27, 2018 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does the SRIW Life Sciences invest in?
the SRIW Life Sciences invests primarily in Biotechnology, Medical and Biopharma startups, most often at Series A and Series B stage. Most of the 3 investments tracked by Shizune back companies in Belgium. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is the SRIW Life Sciences's check size?
the SRIW Life Sciences typically joins rounds of $22M–$23M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds the SRIW Life Sciences participates in.
When did the SRIW Life Sciences last invest?
The most recent investment recorded for the SRIW Life Sciences closed in Nov 2022. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
